FAP and cancer: It is imperative that future studies focus on the potential benefits of increasing cytotoxic or radiotherapeutic drug concentrations near cancer cells through FAP targeting versus the costs of potentially depleting FAP+ stromal cells as a result of using FAP-targeting antibodies.